First Line Metastatic Breast Cancer Treatment (ESMERALDA)

NCT01941407 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
61
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

ARCAGY/ GINECO GROUP